Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide) are all FDA-approved for weight loss in people with obesity or overweight who have a weight-related health condition like high blood pressure, type 2 diabetes, or obstructive sleep apnea
Image credits: fatjoe Many people who turn to weight-loss medications have longstanding struggles with food, self-worth, and emotional painoften stemming from past trauma or emotional abuse, Madsen wrote
Repeated freeze-thaw cycles, which degrade the peptide structure, must be avoided
Providing ease after a long, tiring day
Stromal cell-derived factor-1 (SDF-1)/chemokine (C-X-C motif) receptor 4 (CXCR4) axis activation induces intra-islet glucagon-like peptide-1 (GLP-1) production and enhances beta cell survival